1.00
-0.12(-10.71%)
Currency In CAD
Address
2-1250 Waverley Street
Winnipeg, MB R3T 6C6
Canada
Phone
204 487 7412
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
25
First IPO Date
September 06, 2012
| Name | Title | Pay | Year Born |
| Dr. Albert David Friesen Ph.D. | Founder, Chief Executive Officer & Chairman of the Board | 283,800 | 1947 |
| Mr. Haaris Uddin B.Com., CPA | Chief Financial Officer | 118,000 | N/A |
| Dr. Reuben Saba Ph.D. | Vice President of Scientific & Medical Affairs | 151,000 | N/A |
| Dr. Neil Owens Ph.D. | President & Chief Operating Officer | 236,500 | N/A |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.